The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Liver Hypertrophy: A Review of Adaptive (Adverse and Non-adverse) Changes—Conclusions from the 3rd International ESTP Expert Workshop
Abstract
Preclinical toxicity studies have demonstrated that exposure of laboratory animals to liver enzyme inducers during preclinical safety assessment results in a signature of toxicological changes characterized by an increase in liver weight, hepatocellular hypertrophy, cell proliferation, and, frequently in long-term (life-time) studies, hepatocarcinogenesis. Recent advances over the last decade have revealed that for many xenobiotics, these changes may be induced through a common mechanism of action involving activation of the nuclear hormone receptors CAR, PXR, or PPARα. The generation of genetically engineered mice that express altered versions of these nuclear hormone receptors, together with other avenues of investigation, have now demonstrated that sensitivity to many of these effects is rodent-specific. These data are consistent with the available epidemiological and empirical human evidence and lend support to the scientific opinion that these changes have little relevance to man. The ESTP therefore convened an international panel of experts to debate the evidence in order to more clearly define for toxicologic pathologists what is considered adverse in the context of hepatocellular hypertrophy. The results of this workshop concluded that hepatomegaly as a consequence of hepatocellular hypertrophy without histologic or clinical pathology alterations indicative of liver toxicity was considered an adaptive and a non-adverse reaction. This conclusion should normally be reached by an integrative weight of evidence approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Springer Science+Business Media
Технология (2013) · Betascript Publishing eBooks · Cited by 3,087
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015
Veterinary Hematology and Clinical Chemistry
Sharkey, L. C. (2004) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2004.tb00383.x · Cited by 948
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Kliewer, S. A., Goodwin, B., & Willson, T. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0038 · Cited by 921
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 836
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001215200 · Cited by 815
The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., & Redinbo, M. R. (2001) · Science · doi:10.1126/science.1060762 · Cited by 760
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654 · cited 7×
“It is now well established that the CAR, in a similar manner to other nuclear receptors, mediates the acute and chronic effects induced by Phenobarbitone and TCPOBOP.”
BackgroundInfluentialThe role of oxidative stress in chemical carcinogenesis.
Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., & Walborg, E. F. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106s1289 · Cited by 511
Regulation of cytochrome P450 (CYP) genes by nuclear receptors
Honkakoski, P., & Negishi, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470321 · Cited by 501
Society of Toxicologic Pathology Position Paper: Organ Weight Recommendations for Toxicology Studies
Sellers, R. S., Mortan, D., Michael, B., Roome, N., Johnson, J. K., Yano, B. L., Perry, R., & Schafer, K. (2007) · Toxicologic Pathology · doi:10.1080/01926230701595300 · Cited by 481
Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 479
Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 466
Peroxisome proliferator activated receptor-alpha expression in human liver.
Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · PubMed · Cited by 448
Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300138200 · Cited by 416
Peroxisome Proliferator Activated Receptor-α Expression in Human Liver
Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.14 · Cited by 416
Moore, L. B., Maglich, J. M., McKee, D. D., Wisely, B., Willson, T. M., Kliewer, S. A., Lambert, M. H., & Moore, J. T. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.977 · Cited by 355
Induction of Liver Growth by Xenobiotic Compounds and Other Stimuli
Schulte-Hermann, R. (1974) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447409079856 · Cited by 342
The Ah receptor and the mechanism of dioxin toxicity
Landers, J. P., & Bunce, N. J. (1991) · Biochemical Journal · doi:10.1042/bj2760273 · Cited by 323
Genomics and Proteomics Analysis of Acetaminophen Toxicity in Mouse Liver
Ruepp, S. U. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.1.135 · Cited by 301
Revised guides for organ sampling and trimming in rats and mice – Part 1
Ruehl-Fehlert, C., Kittel, B., Morawietz, G., Deslex, P., Keenan, C., Mahrt, C. R., Nolte, T., Robinson, M., Stuart, B. P., & Deschl, U. (2003) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00311 · Cited by 291
Self-citationHuang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., & Moore, D. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0520 · Cited by 284
The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Fromm, M. F., Kauffmann, H.-M., Fritz, P., Burk, O., Kroemer, H. K., Warzok, R. W., Eichelbaum, M., Siegmund, W., & Schrenk, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64794-3 · Cited by 277
Hepatic peroxisome proliferation in rodents and its significance for humans
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., & Wiegand, H.-J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90225-n · Cited by 271
Self-citationMechanism of indinavir-induced hyperbilirubinemia
Zucker, S. D., Qin, X., Rouster, S. D., Yu, F., Green, R. M., Keshavan, P., Feinberg, J., & Sherman, K. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231140698 · Cited by 262
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
Staudinger, J. L., Liu, Y., Madan, A., Habeebu, S. S., & Klaassen, C. D. (2001) · PubMed · Cited by 260
Robertson, D. G. (2000) · Toxicological Sciences · doi:10.1093/toxsci/57.2.326 · Cited by 255
Ward, J. M., Peters, J. M., Perella, C. M., & Gonzalez, F. J. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600208 · Cited by 249
Serum Transaminase Elevations as Indicators of Hepatic Injury Following the Administration of Drugs
Amacher, D. E. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1201 · Cited by 247
Recognition of Adverse and Nonadverse Effects in Toxicity Studies
Lewis, R. W., Billington, R., Debryune, E., Gamer, A., Lang, B., & Carpanini, F. (2002) · Toxicologic Pathology · doi:10.1080/01926230252824725 · Cited by 246
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244
Self-citationRegulation of Bile Acid and Cholesterol Metabolism by PPARs
Li, T., & Chiang, J. Y. L. (2009) · PPAR Research · doi:10.1155/2009/501739 · Cited by 241
Whysner, J. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00067-8 · Cited by 233
Boone, L., Meyer, D., Cusick, P., Ennulat, D., Bolliger, A. P., Everds, N., Meador, V., Elliott, G., Honor, D., Bounous, D., et al. (2005) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2005.tb00041.x · Cited by 232
Cohen, A. J., & GRASSO, P. (1981) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(81)90509-5 · Cited by 231
A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice
Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., & Schwarz, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0875 · Cited by 228
Post, S. M., Duez, H., Gervois, P. P., Staels, B., Kuipers, F., & Princen, H. M. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098228 · Cited by 217
Gilbert, D., & Golberg, L. (1965) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(65)80129-8 · Cited by 211
Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver
Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W., & Ahr, H. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.004 · Cited by 211
Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity
Williams, G. M., & Iatropoulos, M. J. (2002) · Toxicologic Pathology · doi:10.1080/01926230252824699 · Cited by 189
PLASMA GAMMA-GLUTAMYL TRANSPEPTIDASE ELEVATION IN PATIENTS RECEIVING'ENZYME-INDUCING DRUGS
Rosalki, S. B., Tarlow, D., & Rau, D. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90093-6 · Cited by 187
The mechanisms relating to increases in plasma enzymes and isoenzymes in diseases of animals
Boyd, J. W. (1983) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.1983.tb00609.x · Cited by 184
Hepatic Enzyme Induction: Histopathology
Maronpot, R. R., Yoshizawa, K., Nyska, A., Harada, T., Flake, G., Mueller, G., Singh, B., & Ward, J. M. (2010) · Toxicologic Pathology · doi:10.1177/0192623310373778 · Cited by 182
Self-citationLi, A. P. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00051-0 · Cited by 181
Morimura, K., Cheung, C., Ward, J. M., Reddy, J. K., & Gonzalez, F. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi329 · Cited by 168
FXR and PXR: Potential therapeutic targets in cholestasis
Jonker, J. W., Liddle, C., & Downes, M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.06.012 · Cited by 167
Ross, J., Plummer, S. M., Rode, A., Scheer, N., Bower, C. C., Vogel, O., Henderson, C. J., Wolf, C. R., & Elcombe, C. R. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq118 · Cited by 164
Self-citationThe pregnane X receptor: from bench to bedside
Ma, X., Idle, J. R., & Gonzalez, F. J. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.895 · Cited by 161
Starvation response in mouse liver shows strong correlation with life-span-prolonging processes
Bauer, M., Hamm, A. C., Bonaus, M., Jacob, A., Jaekel, J., Schorle, H., Pankratz, M. J., & Katzenberger, J. D. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00203.2003 · Cited by 158
Echchgadda, I., Song, C. S., Roy, A. K., & Chatterjee, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.720 · Cited by 156
Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats
O'Brien, P. J., Slaughter, M. R., Polley, S. R., & Kramer, K. (2002) · Laboratory Animals · doi:10.1258/002367702320162414 · Cited by 152
Cancer Among Epileptic Patients Exposed to Anticonvulsant Drugs
Olsen, J. H., Boice, J. D., Jensen, J., & Fraumeni, J. F. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.10.803 · Cited by 138
Rhodes, C. J., Orton, T. C., Pratt, I. S., Batten, P. L., Bratt, H., Jackson, S., & Elcombe, C. R. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665299 · Cited by 135
Self-citationMartinez Elizondo, P. (1952) · PubMed · Cited by 135
Weil, C. S., & McCollister, D. D. (1963) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60130a015 · Cited by 130
Bock, K. W., & Köhle, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.004 · Cited by 130
Barbier, O., Villeneuve, L., Bocher, V., Fontaine, C., Pineda‐Torra, I., Duhem, C., Kosykh, V., Fruchart, J., Guillemette, C., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300749200 · Cited by 129
Review article: drug-induced liver injury - its pathophysiology and evolving diagnostic tools
Au, J. S., Navarro, V. J., & Rossi, S. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04674.x · Cited by 125
Cattley, R. C., & Popp, J. A. (1989) · PubMed · Cited by 122
Amacher, D. E., Schomaker, S., & Burkhardt, J. E. (1998) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(98)00066-0 · Cited by 122
Connor, K. T., & Aylward, L. L. (2006) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/15287390500196487 · Cited by 121
Ledwith, B. J., & DeGeorge, J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.273 · Cited by 120
Elcombe, C. R., Rose, M. S., & Pratt, I. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90135-8 · Cited by 119
Self-citationTime and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate
Mitchell, F. E. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90409-0 · Cited by 119
Eschenbrenner, A. B., & Miller, E. (1945) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/5.4.251 · Cited by 119
Conway, J. G., Tomaszewski, K. E., Olson, M. J., Cattley, R. C., Marsman, D. S., & Popp, J. A. (1989) · Carcinogenesis · doi:10.1093/carcin/10.3.513 · Cited by 118
Lake, B. G., Evans, J. G., Gray, T. J. B., Körösi, S. A., & North, C. J. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90120-8 · Cited by 116
Cyclic changes in the glycogen content of the liver and the muscles of rats and mice
Ågren, G., WILANDER, O., & Jorpes, J. E. (1931) · Biochemical Journal · doi:10.1042/bj0250777 · Cited by 114
Fang, H.-L., Strom, S. C., Cai, H., Falany, C. N., Kocarek, T. A., & Runge‐Morris, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005389 · Cited by 112
Effects of Di-isononyl Phthalate, Di-2-ethylhexyl Phthalate, and Clofibrate in Cynomolgus Monkeys
Pugh, G., Isenberg, J. S., Kamendulis, L. M., Ackley, D. C., Clare, L. J., Brown, R., Lington, A. W., Smith, J. H., & Klaunig, J. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.1.181 · Cited by 112
Diurnal Variations in Tissue Glycogen and Liver Weight of Meal-fed Rats
Leveille, G. A., & Chakrabarty, K. (1967) · Journal of Nutrition · doi:10.1093/jn/93.4.546 · Cited by 110
The tissue activities of some diagnostic enzymes in ten mammalian species
Clampitt, R. B., & Hart, R. J. (1978) · Journal of Comparative Pathology · doi:10.1016/0021-9975(78)90014-2 · Cited by 104
Auerbach, S. S., Shah, R., Mav, D., Smith, C. S., Walker, N. J., Vallant, M. K., Boorman, G. A., & Irwin, R. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.11.021 · Cited by 101
Ennulat, D., Walker, D. B., Clemo, F. A. S., Magid-Slav, M., Ledieu, D., Graham, M., Botts, S., & Boone, L. I. (2010) · Toxicologic Pathology · doi:10.1177/0192623310374332 · Cited by 100
Ennulat, D., Magid-Slav, M., Rehm, S., & Tatsuoka, K. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq144 · Cited by 95
Carcinogenic risks of dioxin: Mechanistic considerations
Schwarz, M., & Appel, K. E. (2005) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2005.05.008 · Cited by 92
Lake, B. G. (2009) · Xenobiotica · doi:10.1080/00498250903098184 · Cited by 91
Parzefall, W., Erber, E., Sedivy, R., & Schulte‐Hermann, R. (1991) · PubMed · Cited by 87
Toxicology: Principles and Applications
(2005) · Chemical & Engineering News · doi:10.1021/cen-v083n037.p039 · Cited by 86
Schulte‐Hermann, R., Hoffman, V., Parzefall, W., et al. (1980) · Chemico-Biological Interactions · doi:10.1016/0009-2797(80)90017-4 · Cited by 86
Wang, H., Faucette, S. R., Gilbert, D., Jolley, S. L., Sueyoshi, T., Negishi, M., & LeCluyse, E. L. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.620 · Cited by 84
Hartley, D. P., Dai, X., He, Y. D., Carlini, E. J., Wang, B., Huskey, S.-E. W., Ulrich, R. G., Rushmore, T. H., Evers, R., & Evans, D. C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1159 · Cited by 80
Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver
GRASSO, P., & Hinton, R. H. (1991) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(91)90062-s · Cited by 77
Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver
Cariello, N. F., Romach, E. H., Colton, H. M., Ni, H., Yoon, L., Falls, J. G., Casey, W., Creech, D., Anderson, S. P., Benavides, G. R., et al. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi273 · Cited by 77
Lockard, V. G., Mehendale, H. M., & O’Neal, R. M. (1983) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(83)90054-0 · Cited by 74
Hoivik, D. J., Qualls, C. W., Mirabile, R. C., Cariello, N. F., Kimbrough, C. L., Colton, H. M., Anderson, S. P., Santostefano, M. J., Morgan, R. J. O., Dahl, R. R., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh182 · Cited by 73
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
Pirttiaho, H. I., Sotaniemi, E. A., Pelkonen, R. O., & Pitk�nen, U. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542550 · Cited by 71
Localization and differential induction of cytochrome P450IVA and acyl-CoA oxidase in rat liver
Bell, D., Bars, R., Gibson, G. G., & Elcombe, C. R. (1991) · Biochemical Journal · doi:10.1042/bj2750247 · Cited by 68
Self-citationSerum pseudocholinesterase and very‐low‐density lipoprotein metabolism
Kutty, K. M., & Payne, R. H. (1994) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860080411 · Cited by 67
Carmichael, N. G., Enzmann, H., Pate, I., & Waechter, F. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.971051196 · Cited by 66
Crampton, R. F., Gray, R., GRASSO, P., & Parke, D. V. W. (1977) · Toxicology · doi:10.1016/0300-483x(77)90049-x · Cited by 64
A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens
Felter, S. P., Conolly, R. B., Bercu, J. P., Bolger, P. M., Boobis, A. R., Bos, P. M. J., Carthew, P., Doerrer, N. G., Goodman, J. I., Harrouk, W. A., et al. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.552063 · Cited by 62
Ellinger-Ziegelbauer, H. C., Adler, M., Amberg, A., Brandenburg, A., Callanan, J. J., Connor, S. C., Fountoulakis, M., Gmuender, H., Gruhler, A., Hewitt, P. G., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.022 · Cited by 61
The Perturbation of Apoptosis and Mitosis by Drugs and Xenobiotics
Hasmall, S. C., & Roberts, R. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00058-8 · Cited by 56
Studies on the effects of orally administered di-(2-ethylhexyl) phthalate in the ferret
Lake, B. G., Brantom, P., GANGOLLI, S. D., Butterworth, K. R., & GRASSO, P. (1976) · Toxicology · doi:10.1016/0300-483x(76)90038-x · Cited by 56
Hirose, Y., Nagahori, H., Yamada, T., Deguchi, Y., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S., Isobe, N., Lake, B. G., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.01.007 · Cited by 56
Clayton, N. P., Yoshizawa, K., Kissling, G. E., Burka, L. T., Chan, P., & Nyska, A. (2006) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2006.08.002 · Cited by 54
Greaves, P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-53856-7.00009-9 · Cited by 53
A Critical Comparison of Murine Pathology and Epidemiological Data of TCDD, PCB126, and PeCDF
Yoshizawa, K., Heatherly, A., Malarkey, D. E., Walker, N. J., & Nyska, A. (2007) · Toxicologic Pathology · doi:10.1080/01926230701618516 · Cited by 52
Self-citationPeroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis
Lake, B. G. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03513-3 · Cited by 52
Carmichael, N. G., Bausen, M., Boobis, A. R., Cohen, S. M., Embry, M. R., Fruijtier-Pölloth, C., Greim, H. A., Lewis, R., Meek, M. E., Mellor, H. R., et al. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.541225 · Cited by 51
Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate
Price, S. C., Hinton, R. H., Mitchell, F. E., Hall, D. E., GRASSO, P., Blane, G. F., & Bridges, J. W. (1986) · Toxicology · doi:10.1016/0300-483x(86)90198-8 · Cited by 51
Lkhagvadorj, S., Qu, L., Cai, W., Couture, O. P., Barb, C. R., Hausman, G. J., Nettleton, D. S., Anderson, L. L., Dekkers, J. C. M., & Tuggle, C. K. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90372.2008 · Cited by 51
Species differences in peroxisome proliferation; mechanisms and relevance
Choudhury, A. I., Chahal, S., Bell, A. R., Tomlinson, S. R., Roberts, R. A., Salter, A. M., & Bell, D. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00237-7 · Cited by 50
Morphogenesis of Postmortem Hepatocyte Vacuolation and Liver Weight Increases in Sprague-Dawley Rats
Li, X., Elwell, M. R., Ryan, A. M., & Ochoa, R. (2003) · Toxicologic Pathology · doi:10.1080/01926230390241981 · Cited by 50
Hepatotoxicity induced by cyproterone acetate: A report of three cases
Savidou, I., Deutsch, M., Soultati, A. S., Koudouras, D., Kafiri, G., & Dourakis, S. P. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7551 · Cited by 50
Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver
Roglans, N., Bellido, A., Rodríguez, C., Cabrero, Á., Novell, F., Ros, E., Zambón, D., & Laguna, J. C. (2002) · Clinical pharmacology and therapy · doi:10.1067/mcp.2002.128605 · Cited by 49
Kramer, J. A., Blomme, E. A. G., Bunch, R. T., Davila, J. C., Jackson, C. J., Jones, P. F., Kolaja, K. L., & Curtiss, S. W. (2003) · Toxicologic Pathology · doi:10.1080/01926230309726 · Cited by 49
Diwan, B. A., Lubet, R. A., Ward, J. M., Hrabie, J. A., & Rice, J. M. (1992) · Carcinogenesis · doi:10.1093/carcin/13.10.1893 · Cited by 45
Knight, J. A. (2005) · Journal of Infusion Nursing · doi:10.1097/00129804-200503000-00004 · Cited by 44
Rajvanshi, P., Liu, D., Ott, M., Gagandeep, S., Schilsky, M. L., & Gupta, S. K. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4223 · Cited by 42
Plant, N. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1521 · Cited by 40
Mechanism‐based Risk Assessment of Peroxisome Proliferating Rodent Hepatocarcinogens
Williams, G. M., & Perrone, C. E. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18645.x · Cited by 37
Wang, T., Papoutsi, M., Wiesmann, M., DeCristofaro, M. F., Keselica, M., Skuba, E., Spaet, R. H., Markovits, J., Wolf, A., Moulin, P., et al. (2011) · International Journal of Toxicology · doi:10.1177/1091581811401920 · Cited by 36
Crampton, R. F., Gray, T. J. B., GRASSO, P., & Parke, D. V. W. (1977) · Toxicology · doi:10.1016/0300-483x(77)90050-6 · Cited by 35
Effect of phenobarbitone on plasma and hepatic alkaline phosphatase activity in the dog
Litchfield, M. H., & Conning, D. M. (1972) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499047 · Cited by 31
Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis
Cattley, R. C. (2004) · Toxicologic Pathology · doi:10.1080/01926230490451680 · Cited by 31
Beebe, L. E., Fornwald, L. W., Diwan, B. A., Anver, M. R., & Anderson, L. M. (1995) · PubMed · Cited by 31
Schäfer, S., HANSEN, B. C., Völkl, A., Fahimi, H. D., & Pill, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.004 · Cited by 30
Nuclear receptors: the controlling force in drug metabolism of the liver?
Plant, N. J., & Aouabdi, S. (2009) · Xenobiotica · doi:10.1080/00498250903098218 · Cited by 28
The Use of Metabolomics in Cancer Research
van Ravenzwaay, B., Cunha, G. C.-P., Fabian, E. J., Herold, M. J., Kamp, H., Krennrich, G., Krotzky, A. J., Leibold, E., Looser, R., Mellert, W., et al. (2009) · Springer eBooks · doi:10.1007/978-90-481-2675-0_8 · Cited by 28
Self-citationRegulation of cell proliferation and cell death by peroxisome proliferators
Cattley, R. C. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10327 · Cited by 25
Gene Expression Analysis Offers Unique Advantages to Histopathology in Liver Biopsy Evaluations
Heinloth, A. N., Boorman, G. A., Foley, J. F., et al. (2007) · Toxicologic Pathology · doi:10.1080/01926230601178207 · Cited by 25
Poulsen, H. E., Lerche, A., & Pedersen, N. T. (2008) · Pharmacology · doi:10.1159/000138057 · Cited by 21
Greaves, P. (2007) · Elsevier eBooks · doi:10.1016/b978-044452771-4/50010-9 · Cited by 21
Greenberg, M., & Lowrie, K. W. (2011) · Risk Analysis · doi:10.1111/j.1539-6924.2011.01712.x · Cited by 19
THE EFFECTS OF FASTING ON CORE TEMPERATURE, BLOOD GLUCOSE AND BODY AND ORGAN WEIGHTS IN RATS
Chatamra, K., Daniel, P. M., & Lam, D. K. C. (1984) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1984.sp002840 · Cited by 16
Effects of Variation of Necropsy Time and Fasting on Liver Weights and Liver Components in Rats
Rothacker, D. L., Kanerva, R. L., Wyder, W. E., Alden, C. L., & Maurer, J. K. (1988) · Toxicologic Pathology · doi:10.1177/019262338801600103 · Cited by 16
Inhibition and induction of bile acid synthesis by ketoconazole effects on bile formation in the rat
Kuipers, F., Havinga, R., Huijsmans, C. M. G., Vonk, R. J., & Princen, H. M. G. (1989) · Lipids · doi:10.1007/bf02544580 · Cited by 13
Subacute and Subchronic Toxicology Studies of CI-986, a Novel Anti-inflammatory Compound
Robertson, D. (1993) · Fundamental and Applied Toxicology · doi:10.1006/faat.1993.1055 · Cited by 11
Huang, H.-L., & Shaw, N.-S. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9378 · Cited by 10
Hirayanagi, N., Fujii, E., & Teshirogi, T. (1991) · Journal of Nippon Medical School · doi:10.1272/jnms1923.58.547 · Cited by 3
Cited by
Costello, E., Rock, S., Stratakis, N., Eckel, S. P., Walker, D. I., Valvi, D., Cserbik, D., Jenkins, T., Xanthakos, S. A., Kohli, R., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10092 · Cited by 420
EFSA Panel on Food Contact Materials, E. A. P. A. (., Lambré, C., Barat Baviera, J. M., Bolognesi, C., Chesson, A., Cocconcelli, P. S., Crebelli, R., Gott, D. M., Grob, K., Lampi, E., et al. (2023) · EFSA Journal · doi:10.2903/j.efsa.2023.6857 · Cited by 397
Risk Assessment of Per- and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach
Bil, W., Zeilmaker, M., Fragki, S., Lijzen, J., Verbruggen, E., & Bokkers, B. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4835 · Cited by 158
“2015; National Toxicology Program 2019a, 2019b), which is not typically part of the rodent liver response to PPARα proliferators (Hall et al. 2012).”
BackgroundGoodrum, P. E., Anderson, J. K., Luz, A. L., & Ansell, G. K. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfaa123 · Cited by 118
Jiang, Y., Feng, D., Ma, X., Fan, S., Gao, Y., Fu, K., Wang, Y., Sun, J., Yao, X., Liu, C., et al. (2019) · Hepatology · doi:10.1002/hep.30131 · Cited by 103
Metadata
- Authors
- Hall, A. P., Elcombe, C. R., Foster, J. R., Harada, T., Kaufmann, W., Knippel, A., Küttler, K., Malarkey, D. E., Maronpot, R. R., Nishikawa, A., Nolte, T., Schulte, A., Strauss, V., & York, M. J.
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2012-06-21
- Volume
- 40
- Issue
- 7
- Pages
- 971-994
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2096945589
- Cited by
- 427
- References
- 138
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.